TrkC binds to the type II TGF-beta receptor to suppress TGF-beta signaling (Q40124461)

17 September 2017

title

TrkC binds to the type II TGF-beta receptor to suppress TGF-beta signaling (English)

1 reference

17 September 2017

W Jin

1

1 reference

17 September 2017

C Yun

2

1 reference

17 September 2017

M-K Kwak

3

1 reference

17 September 2017

T-A Kim

4

1 reference

17 September 2017

S-J Kim

5

1 reference

17 September 2017

language of work or name

English

0 references

publication date

4 June 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

26

1 reference

17 September 2017

issue

55

1 reference

17 September 2017

page(s)

7684-7691

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

17 September 2017

1 reference

Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

Mutational analysis of the tyrosine kinome in colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Expression of TrkA, TrkB and TrkC in human neuroblastomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Neurotrophins: to cleave or not to cleave

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Expression of p75(LNGFR) and Trk neurotrophin receptors in normal and neoplastic human prostate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Gene expression of TrkC (NTRK3) in human soft tissue tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Neurotrophin-3 mediates the autocrine survival of the catecholaminergic CAD CNS neuronal cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-beta signaling by inactivating the TGF-beta type II receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Tumor suppressor activity of the TGF-beta pathway in human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

TGF-beta signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Trk receptor tyrosine kinases: a bridge between cancer and neural development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Autocrine expression of neurotrophins and their receptors in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

TGF beta signals through a heteromeric protein kinase receptor complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Expression and function of Trk-C in favourable human neuroblastomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Human Smad3 and Smad4 are sequence-specific transcription activators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210571

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210571

1 reference

Dimensions Publication ID

17 September 2017

1012885654

0 references

1 reference